Novel modality share of oncology trials
Share of oncology clinical trials using novel modalities such as cell and gene therapies, ADCs, and multispecific antibodies.
Unit Percent Industry Healthcare
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2024
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global Oncology Trends 2025 | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Novel modality share of oncology trials. Retrieved from https://statorigin.org/indicators/novel-modality-share-of-oncology-trials